Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1755 ARTÍCULOS , VIENDO DEL 946 AL 960

Quantification of amyloid PET for future clinical use: a state-of-the-art review

Pemberton HG, Collij LE, Heeman F, Bollack A, Shekari M, Salvadó G, Alves IL, Garcia DV, Battle M, Buckley C, Stephens AW, Bullich S, Garibotto V, Barkhof F, Gispert JD, Farrar G; AMYPAD consortium.

Eur J Nucl Med Mol Imaging. 2022 Aug;49(10):3508-3528. doi: 10.1007/s00259-022-05784-y. Epub 2022 Apr 7.

Association of Blood Amyloid Beta-Protein 1-42 with Poststroke Cognitive Impairment: A Systematic Review and Meta-Analysis

Chen H, Gu S, Liu X, Xie A, Wang C.

Biomed Res Int. 2022 Mar 30;2022:6552781. doi: 10.1155/2022/6552781. eCollection 2022.

Late-onset epilepsy and the risk of dementia: a systematic review and meta-analysis

Huang L, Fu C, Li J, Peng S.

Aging Clin Exp Res. 2022 Aug;34(8):1771-1779. doi: 10.1007/s40520-022-02118-8. Epub 2022 Apr 15.

The relationship of early- and late-onset Alzheimer's disease genes with COVID-19

Sirin S, Nigdelioglu Dolanbay S, Aslim B.

J Neural Transm (Vienna). 2022 Jul;129(7):847-859. doi: 10.1007/s00702-022-02499-0. Epub 2022 Apr 16.

Cross-Cultural Longitudinal Study on Cognitive Decline (CLoCODE) for Subjective Cognitive Decline in China and Germany: A Protocol for Study Design

Sheng C, Yang K, He B, Li T, Wang X, Du W, Hu X, Jiang J, Jiang X, Jessen F, Han Y.

J Alzheimers Dis. 2022;87(3):1319-1333. doi: 10.3233/JAD-215452.

The Relationship Between Sleep Disturbance and Apolipoprotein E ε4 in Adults With Mild Cognitive Impairment and Alzheimer's Disease Dementia: An Integrative Review

Wei W, Wang K, Shi J, Li Z.

Biol Res Nurs. 2022 Jul;24(3):327-337. doi: 10.1177/10998004221081044. Epub 2022 Apr 19.

Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer's disease

Assunção SS, Sperling RA, Ritchie C, Kerwin DR, Aisen PS, Lansdall C, Atri A, Cummings J.

Alzheimers Res Ther. 2022 Apr 19;14(1):54. doi: 10.1186/s13195-022-00984-y.

Mechanisms Involved in Epileptogenesis in Alzheimer's Disease and Their Therapeutic Implications

Altuna M, Olmedo-Saura G, Carmona-Iragui M, Fortea J.

Int J Mol Sci. 2022 Apr 13;23(8):4307. doi: 10.3390/ijms23084307.

Beyond amyloid: Immune, cerebrovascular, and metabolic contributions to Alzheimer disease in people with Down syndrome

Martini AC, Gross TJ, Head E, Mapstone M.

Neuron. 2022 Jul 6;110(13):2063-2079. doi: 10.1016/j.neuron.2022.04.001. Epub 2022 Apr 25.

Brain Metabolism and Amyloid Load in Individuals With Subjective Cognitive Decline or Pre-Mild Cognitive Impairment

Tondo G, Boccalini C, Vanoli EG, Presotto L, Muscio C, Ciullo V, Banaj N, Piras F, Filippini G, Tiraboschi P, Tagliavini F, Frisoni GB, Cappa SF, Spalletta G, Perani D; Network-AD project.

Neurology. 2022 Jul 18;99(3):e258-e269. doi: 10.1212/WNL.0000000000200351.

Therapeutic news in Alzheimer's disease: Soon a disease-modifying therapy?

Villain N.

Rev Neurol (Paris). 2022 May;178(5):437-440. doi: 10.1016/j.neurol.2022.02.456. Epub 2022 Apr 28.

Brain Photobiomodulation Improves Sleep Quality in Subjective Cognitive Decline: A Randomized, Sham-Controlled Study

Zhao X, Du W, Jiang J, Han Y.

J Alzheimers Dis. 2022;87(4):1581-1589. doi: 10.3233/JAD-215715.

Promise of irisin to attenuate cognitive dysfunction in aging and Alzheimer's disease

Madhu LN, Somayaji Y, Shetty AK.

Ageing Res Rev. 2022 Jun;78:101637. doi: 10.1016/j.arr.2022.101637. Epub 2022 Apr 30.

Diagnostic performance of hippocampal volumetry in Alzheimer's disease or mild cognitive impairment: a meta-analysis

Park HY, Suh CH, Heo H, Shim WH, Kim SJ.

Eur Radiol. 2022 Oct;32(10):6979-6991. doi: 10.1007/s00330-022-08838-9. Epub 2022 May 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias